CNSP
CNS Pharmaceuticals, Inc.Company with tickers: CNSP
CIK
1729427
CUSIP
18978H508
Shares Outstanding
1,461,449
Website
https://www.cnspharma.com
Investor Relations
https://cnspharma.com/ir/
13F Activity (30d)
7 filings
7 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | — | ||||
| Operating Income | — | ||||
| Net Income | — | ||||
| EPS (Basic) | — | ||||
| EPS (Diluted) | — |